Histidine decarboxylase inhib 
Welcome,         Profile    Billing    Logout  
  Companies   Products    Products    Diseases    Trials    News 
  • ||||||||||  Journal:  Antagonism of histamine H receptor promotes angiogenesis following focal cerebral ischemia. (Pubmed Central) -  Nov 3, 2022   
    In conclusion, this study demonstrates that HR antagonism promotes angiogenesis after cerebral ischemia, which is independent of activation of histaminergic neurons, but related to the HR on vascular endothelial cells and its interaction with Annexin A2. Thus, HR antagonists might be promising drug candidates to improve angiogenesis and neurological recovery after ischemic stroke.
  • ||||||||||  carboplatin / Generic mfg.
    Journal:  Histidine decarboxylase inhibitors: a novel therapeutic option for the treatment of leydigioma. (Pubmed Central) -  Oct 6, 2022   
    We, therefore, evaluated for the first time the antitumor efficacy of two histidine decarboxylase inhibitors (α-methyl-dl-histidine dihydrochloride (α-MHD) and epigallocatechin gallate (EGCG)), alone and combined with carboplatin, in two preclinical models of LCT...Testicular and body weights remained unaltered. On the basis of this study, histidine decarboxylase may emerge as a novel pharmacological target for LCT treatment.
  • ||||||||||  Nitredon (nitrazepam) / Remedica
    Journal:  Effects of Histamine and Related Compounds on the Central Nervous System (Pubmed Central) -  Feb 16, 2021   
    On the other hand, no significant effects were observed with second generation H-antagonists. These findings suggest that histamine plays an important role in learning and memory via H-receptors, an inhibition of amygdaloid kindled seizures induced by histamine occurred through not only H-receptors but also H-receptors, and that classic H-antagonists can be useful as a effective hypnotic for difficulty in falling asleep.
  • ||||||||||  carbidopa / Generic mfg.
    [VIRTUAL] Histaminergic basis of fatigue in Multiple Sclerosis () -  Sep 3, 2020 - Abstract #MSDC2020MSDC_1585;    
    Conversion systemically from l-histidine to histamine was blocked using histidine decarboxylase inhibitor, lodosyn, which has no access to the brain across the blood brain barrier.All subjects received a fixed dose lodosyn, 50 mg po bid...This novel approach opens up a new avenue to identify drugs that raise brain histamine as a mechanism of treatment of fatigue in MS and possibly other disorders with fatigue where histamine may play a pivotal role in the pathogenesis of this common and severely disabling symptom. Additionally this treatment could also provide an approach to help cognitive impairment in multiple sclerosis since raising brain histamine can facilitate also the enhanced release of a number of neurotransmitters including acetylcholine, implicated in the pathogenesis of cognitive impairment in various disorders including multiple sclerosis.
  • ||||||||||  Journal:  Repurposing a Histamine Detection Platform for High-Throughput Screening of Histidine Decarboxylase. (Pubmed Central) -  Sep 20, 2019   
    A pilot HTS screen gave a Z' score > 0.5 and a hit rate of 1.1%, and led to the identification of a validated hit series. Overall, the presented assay should facilitate the discovery of therapeutic HDC inhibitors by acting as a novel tool suitable for large-scale HTS and subsequent interrogation of compound structure-activity relationships.
  • ||||||||||  Journal:  Lipidated connexin mimetic peptides potently inhibit gap junction-mediated Ca-wave propagation. (Pubmed Central) -  Jul 4, 2019   
    Selective inhibition of intercellular Ca signaling, likely indicative of channel conformation-specific SRPTEKT-Hdc binding, could contribute significantly to the protective effects of these mimetic peptides in settings of injury. Our data also demonstrate that lipidation represents a paradigm for development of highly potent, efficacious and selective mimetic peptide inhibitors of hemichannel and gap junction channel-mediated signaling.
  • ||||||||||  Journal:  The ellagitannin trimer rugosin G inhibits recombinant human histidine decarboxylase. (Pubmed Central) -  Apr 18, 2019   
    Rugosin G showed potent inhibition compared to ellagitannin monomers and a dimer with macrocyclic structure (oenothein B), suggesting the potent inhibition of rugosin G was attributed to its linear oligomeric conformation. Abbreviations: HDC, histidine decarboxylase; Me2CO, acetone; EtOAc, ethyl acetate.
  • ||||||||||  Journal:  Inhibiting Histamine Signaling Ameliorates Vertigo Induced by Sleep Deprivation. (Pubmed Central) -  Apr 16, 2019   
    Upregulated HDC in the vestibular and increased CSF concentration of histamine can be detected in the SD mice, indicating vestibular dysfunction which can be ameliorated by both BHOA and DPHM. Histamine signaling inhibition may ameliorate SD-induced vertigo, and histamine can be considered as a potential treatment target.